跳至主要内容
临床试验/IRCT20180205038626N15
IRCT20180205038626N15招募中3 期

Comparison of the effect of oral and intravenous iron supplementation on quality of life and function of patients with heart failure: a randomized clinical trial

Rasht University of Medical Sciences0 个研究点目标入组 180 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with heart failure
  • Age above 18 years
  • Serum ferritin levels <100 or TS <20%
  • Ferritin 100-300 and hemoglobin below 15

排除标准

  • Known and treated anemia
  • Allergy or intolerance to iron supplements
  • Duodenal or gastric ulcer, gastrointestinal disease with impaired iron absorption
  • Oncological diseases
  • History of surgery 6 months before entering the study
  • Active bleeding and the need for blood transfusion in patients with shock or sepsis
  • Unwillingness to continue the study or cause any dissatisfaction in the field of taking iron supplements or participating in the study
  • Acute heart failure

研究者

发起方
Rasht University of Medical Sciences

相似试验

Comparison of the effect of oral and intravenous... | 临床试验